Punith Kempegowda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Punith Kempegowda has a total of 466 co-authors. Here are the top co-authors by number of shared publications:
Eka Melson
Institute of Clinical Sciences, Imperial College London, London, United Kingdom
20 shared publicationsMeri Davitadze
Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
20 shared publicationsDengyi Zhou
London North West University Healthcare NHS Trust London UK
15 shared publications- Eka Melson
Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK
15 shared publications Lucretia Thomas
University of Birmingham College of Medical and Dental Sciences Birmingham B4 6BN, United Kingdom
14 shared publicationsWentin Chen
University of Birmingham College of Medical and Dental Sciences Birmingham B4 6BN, United Kingdom
14 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Diabetic Ketoacidosis: Systematic Review and Meta‐Analysis
Aims: Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a systematic review and meta‐analysis to evaluate the precipitants, management and outcomes of adult DKA. Materials and Methods: We searched PubMed, Embase, Web of Science, Scopus, MEDLINE, CINAHL and ERIC from 2000 to April 2026 for studies reporting precipitating factors, management and outcomes among adults (≥ 16 years) with DKA. Articles that did not report all three were excluded. Two reviewers independently screened studies, extracted data and assessed risk of bias. Descriptive synthesis was performed for demographic, biochemical, management and outcome variables. A random‐effects meta‐analysis estimated summary in‐hospital all‐cause mortality. This review was registered with PROSPERO (ID: CRD42025641665). https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641665 . Results: Nineteen studies met the inclusion criteria, of which 15 studies comprising 1278 DKA episodes contributed to the descriptive synthesis and nine studies including 724 participants to the mortality meta‐analysis. Most episodes were classified as moderate or severe DKA. Preadmission glycaemic control was frequently suboptimal. Missed or inadequate diabetes medication was the commonest precipitant (42.2%), followed by infection (28.6%) and newly diagnosed diabetes (11.2%). Substantial regional variation was observed in guideline use, insulin and fluid administration, intensive care admission and treatment‐related complications. The in‐hospital mortality summary estimate was 2.17% (95% CI, 0.93%–4.99%). Conclusion: Medication omission and infection remain the dominant precipitants of adult DKA worldwide. Marked variation in management practices and outcomes persists across healthcare systems, suggesting inconsistent implementation of DKA care pathways.
- 9 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Open AccessDiabetic Ketoacidosis: Systematic Review and Meta‐Analysis
Aims: Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a systematic review and meta‐analysis to evaluate the precipitants, management and outcomes of adult DKA. Materials and Methods: We searched PubMed, Embase, Web of Science, Scopus, MEDLINE, CINAHL and ERIC from 2000 to April 2026 for studies reporting precipitating factors, management and outcomes among adults (≥ 16 years) with DKA. Articles that did not report all three were excluded. Two reviewers independently screened studies, extracted data and assessed risk of bias. Descriptive synthesis was performed for demographic, biochemical, management and outcome variables. A random‐effects meta‐analysis estimated summary in‐hospital all‐cause mortality. This review was registered with PROSPERO (ID: CRD42025641665). https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641665 . Results: Nineteen studies met the inclusion criteria, of which 15 studies comprising 1278 DKA episodes contributed to the descriptive synthesis and nine studies including 724 participants to the mortality meta‐analysis. Most episodes were classified as moderate or severe DKA. Preadmission glycaemic control was frequently suboptimal. Missed or inadequate diabetes medication was the commonest precipitant (42.2%), followed by infection (28.6%) and newly diagnosed diabetes (11.2%). Substantial regional variation was observed in guideline use, insulin and fluid administration, intensive care admission and treatment‐related complications. The in‐hospital mortality summary estimate was 2.17% (95% CI, 0.93%–4.99%). Conclusion: Medication omission and infection remain the dominant precipitants of adult DKA worldwide. Marked variation in management practices and outcomes persists across healthcare systems, suggesting inconsistent implementation of DKA care pathways.
- Open Access
- 3 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Closed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
Aims: Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety, efficacy, and implementation of CL systems in inpatient care. Materials and Methods: This review followed PRISMA guidelines (PROSPERO: CRD420251133486). Eligible studies reported glycaemic, safety, and/or implementation outcomes for adults managed with CL systems in inpatient care. EMBASE, PubMed, MEDLINE, Scopus, CINAHL, and Cochrane Library were searched from inception to August 2026. Risk of bias was assessed using RoB2 and ROBINS‐I. Random‐effects meta‐analysis evaluated glycaemic outcomes and length of stay (LOS). Results were presented as pooled mean differences (MDs) and 95% confidence intervals (CIs). Implementation data were analysed thematically. Intrapartum outcomes were analysed separately. Results: Thirteen inpatient studies were included, nine contributing to meta‐analysis. CL delivery increased time in range (MD +22.27%, 95% CI: 16.03–28.51; p < 0.001) and reduced time above range (MD −23.75%, 95% CI: −28.05 to −19.45; p < 0.001), mean glucose (MD −1.66 mmol/L, 95% CI: −2.29 to −1.03; p < 0.001) and glucose standard deviation (MD −0.64 mmol/L, 95% CI: −0.85 to −0.43; p < 0.001). No significant differences were observed in time below range, coefficient of variation or LOS. Total daily insulin dose was higher (MD +10.82 IU/day, 95% CI: 0.02–21.62; p = 0.05). No serious device‐attributed adverse events were reported. Implementation challenges included staff training, technical support, and workflow integration. Four additional intrapartum studies were included; two contributed to the meta‐analysis, showing increased pregnancy‐specific time in range (MD +11.82%, 95% CI: 5.56–18.08; p < 0.001). Conclusion: CL systems improve inpatient glycaemic control, although effects on LOS and comparative safety remain uncertain. Wider adoption requires sustainable technical and organisational support.
- 3 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Open AccessClosed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
Aims: Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety, efficacy, and implementation of CL systems in inpatient care. Materials and Methods: This review followed PRISMA guidelines (PROSPERO: CRD420251133486). Eligible studies reported glycaemic, safety, and/or implementation outcomes for adults managed with CL systems in inpatient care. EMBASE, PubMed, MEDLINE, Scopus, CINAHL, and Cochrane Library were searched from inception to August 2026. Risk of bias was assessed using RoB2 and ROBINS‐I. Random‐effects meta‐analysis evaluated glycaemic outcomes and length of stay (LOS). Results were presented as pooled mean differences (MDs) and 95% confidence intervals (CIs). Implementation data were analysed thematically. Intrapartum outcomes were analysed separately. Results: Thirteen inpatient studies were included, nine contributing to meta‐analysis. CL delivery increased time in range (MD +22.27%, 95% CI: 16.03–28.51; p < 0.001) and reduced time above range (MD −23.75%, 95% CI: −28.05 to −19.45; p < 0.001), mean glucose (MD −1.66 mmol/L, 95% CI: −2.29 to −1.03; p < 0.001) and glucose standard deviation (MD −0.64 mmol/L, 95% CI: −0.85 to −0.43; p < 0.001). No significant differences were observed in time below range, coefficient of variation or LOS. Total daily insulin dose was higher (MD +10.82 IU/day, 95% CI: 0.02–21.62; p = 0.05). No serious device‐attributed adverse events were reported. Implementation challenges included staff training, technical support, and workflow integration. Four additional intrapartum studies were included; two contributed to the meta‐analysis, showing increased pregnancy‐specific time in range (MD +11.82%, 95% CI: 5.56–18.08; p < 0.001). Conclusion: CL systems improve inpatient glycaemic control, although effects on LOS and comparative safety remain uncertain. Wider adoption requires sustainable technical and organisational support.
- Open Access
- 29 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
Educational Preferences in PCOS/PMOS: A Multicentre, Multilanguage Exploration of Socioeconomic and Linguistic Determinants
Purpose: To evaluate educational preferences in PCOS/PMOS and the influence of socioeconomic status, language, and culture. Methods: This multicentre mixed-methods study was conducted across five centres through convenience sampling. Women aged ≥18 years with PCOS/PMOS consented to a survey. Participants were provided with multilingual videos, English-language leaflets, and a mobile application, followed by semi-structured interviews in their native languages. To ensure robust multivariable analysis while achieving within-site thematic saturation and cross-site comparability, we targeted 100 quantitative and 25 qualitative participants per site. Data analysis involved descriptive statistics, multinomial logistic regression, and thematic coding. Results: Among 524 women with PCOS/PMOS (median age 27 years, IQR 23–31) across India (40.1%), Greece (20.4%), Turkey (20.4%), and the UK (19.1%), videos were the most preferred medium (58.4%), followed by leaflets (20.8%) and mobile applications (13.4%). Preferences differed significantly by language (p < 0.001) and income (p = 0.002). Compared to English-speakers, Hindi- (OR = 6.20, 95%CI = 1.31–29.2) and Marathi-speakers (OR = 27.2, 95%CI = 2.96–250) were more favoured videos over leaflets, while Turkish-speakers least preferred mobile applications (OR = 0.29, 95% CI 0.09–0.88). Women with lower income and education were more likely to favour native-language videos. Among 125 interviewees, 56.1% deemed videos the most useful due to clarity, though they requested more cultural diversity. Leaflets were viewed as credible but dense; mobile applications were perceived as impersonal. Conclusions: Video-based, particularly native-language education is the preferred medium for women with PCOS/PMOS. Language is the strongest predictor of preference. Culturally tailored multimedia resources may improve understanding, engagement, and equity in PCOS/PMOS care.
- 29 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
Open AccessEducational Preferences in PCOS/PMOS: A Multicentre, Multilanguage Exploration of Socioeconomic and Linguistic Determinants
Purpose: To evaluate educational preferences in PCOS/PMOS and the influence of socioeconomic status, language, and culture. Methods: This multicentre mixed-methods study was conducted across five centres through convenience sampling. Women aged ≥18 years with PCOS/PMOS consented to a survey. Participants were provided with multilingual videos, English-language leaflets, and a mobile application, followed by semi-structured interviews in their native languages. To ensure robust multivariable analysis while achieving within-site thematic saturation and cross-site comparability, we targeted 100 quantitative and 25 qualitative participants per site. Data analysis involved descriptive statistics, multinomial logistic regression, and thematic coding. Results: Among 524 women with PCOS/PMOS (median age 27 years, IQR 23–31) across India (40.1%), Greece (20.4%), Turkey (20.4%), and the UK (19.1%), videos were the most preferred medium (58.4%), followed by leaflets (20.8%) and mobile applications (13.4%). Preferences differed significantly by language (p < 0.001) and income (p = 0.002). Compared to English-speakers, Hindi- (OR = 6.20, 95%CI = 1.31–29.2) and Marathi-speakers (OR = 27.2, 95%CI = 2.96–250) were more favoured videos over leaflets, while Turkish-speakers least preferred mobile applications (OR = 0.29, 95% CI 0.09–0.88). Women with lower income and education were more likely to favour native-language videos. Among 125 interviewees, 56.1% deemed videos the most useful due to clarity, though they requested more cultural diversity. Leaflets were viewed as credible but dense; mobile applications were perceived as impersonal. Conclusions: Video-based, particularly native-language education is the preferred medium for women with PCOS/PMOS. Language is the strongest predictor of preference. Culturally tailored multimedia resources may improve understanding, engagement, and equity in PCOS/PMOS care.
- Open Access
- 10 October 2026
- Published by Wiley in Diabetic Medicine
- p. e70488
Ethnicity is associated with variation in diabetes emergency outcomes: Findings from the DEKODE audit and feedback programme
Background: Although ethnic disparities in diabetes prevalence and chronic complications are well recognised, their association with acute metabolic emergencies and outcomes is not well established. In this study, we investigated the association between ethnicity and clinical outcomes. Methods: This retrospective multicentre study included adults (≥16 years) admitted with diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS) and hypoglycaemia between 2020 and 2023 in participating centres of the Digital Evaluation of Ketosis and Other Diabetes Emergencies (DEKODE) surveillance programme. Ethnicity was grouped as White, Asian or Black. Multivariable linear and logistic regression models assessed associations between ethnicity and length of stay (LOS), episode duration and in‐hospital mortality, adjusting for demographic, biochemical and clinical covariates. Results: A total of 6859 episodes were analysed (4257 DKA; 191 HHS; 2411 hypoglycaemia). Across these, differences were observed in age at presentation, metabolic parameters, and LOS across ethnic groups. In DKA, Black and Asian ethnicities were associated with longer LOS than White ethnicity ( p < 0.001). Black ethnicity was also associated with prolonged DKA duration ( p = 0.006). In the HHS cohort, Asian ethnicity was associated with longer LOS ( p = 0.014) but lower in‐hospital mortality ( p = 0.002). In the hypoglycaemia cohort, Black ethnicity was associated with lower mortality ( p = 0.037). Conclusions: Ethnic variation was observed in the presentation and outcomes of diabetic emergencies. After adjustment for demographic and clinical factors, ethnicity remained associated with several outcomes. These findings support further investigation into social, healthcare and pre‐hospital factors that may contribute to observed differences.
- 10 October 2026
- Published by Wiley in Diabetic Medicine
- p. e70488
Open AccessEthnicity is associated with variation in diabetes emergency outcomes: Findings from the DEKODE audit and feedback programme
Background: Although ethnic disparities in diabetes prevalence and chronic complications are well recognised, their association with acute metabolic emergencies and outcomes is not well established. In this study, we investigated the association between ethnicity and clinical outcomes. Methods: This retrospective multicentre study included adults (≥16 years) admitted with diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS) and hypoglycaemia between 2020 and 2023 in participating centres of the Digital Evaluation of Ketosis and Other Diabetes Emergencies (DEKODE) surveillance programme. Ethnicity was grouped as White, Asian or Black. Multivariable linear and logistic regression models assessed associations between ethnicity and length of stay (LOS), episode duration and in‐hospital mortality, adjusting for demographic, biochemical and clinical covariates. Results: A total of 6859 episodes were analysed (4257 DKA; 191 HHS; 2411 hypoglycaemia). Across these, differences were observed in age at presentation, metabolic parameters, and LOS across ethnic groups. In DKA, Black and Asian ethnicities were associated with longer LOS than White ethnicity ( p < 0.001). Black ethnicity was also associated with prolonged DKA duration ( p = 0.006). In the HHS cohort, Asian ethnicity was associated with longer LOS ( p = 0.014) but lower in‐hospital mortality ( p = 0.002). In the hypoglycaemia cohort, Black ethnicity was associated with lower mortality ( p = 0.037). Conclusions: Ethnic variation was observed in the presentation and outcomes of diabetic emergencies. After adjustment for demographic and clinical factors, ethnicity remained associated with several outcomes. These findings support further investigation into social, healthcare and pre‐hospital factors that may contribute to observed differences.
- Open Access
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1862035
Implementing a multi-centre hypoglycaemia management surveillance model through a co-designed approach to develop actionable insights in the UK
Introduction: Severe hypoglycaemia is associated with increased mortality. While considered a never event, severe hypoglycaemias continue occurring in people admitted to hospital. Inconsistent data collection and surveillance limits our ability to assess trends, identify risk factors and implement targeted interventions. This study aimed to (1) co-design a multicentre audit model for inpatient hypoglycaemia (2), evaluate its acceptability and feasibility and (3) analyse hypoglycaemia management to inform quality improvement initiatives. Methods: A hypoglycaemia audit system was co-designed with diabetes specialists, resident doctors and medical students, guided by ERIC study recommendations and the CFIR framework. Piloted at one site, it then expanded to ten hospitals, where feasibility and acceptability were evaluated using stakeholder feedback and system performance. The model was delivered via Plan-Do-Study-Act cycles and train-the-trainer methods. Data on demographics, precipitants, treatments, and outcomes of clinically significant hypoglycaemias in people with diabetes were analysed to identify risk factors and adherence to guidelines. End-user and expert feedback informed system validation. Results: The system was refined via stakeholder input and Plan-Do-Study-Act cycles to ensure usability before expanding to ten hospitals, where it achieved high acceptability. Over 11 months, 1,451 severe hypoglycaemias in 945 patients were recorded. Common precipitants included illness and missed meals. Management varied significantly between hospitals, e.g., glucagon use ranged from 2.6% (Hospital C) to 38.7% (Hospital E). Two hospitals within the same NHS trust showed differences in hypoglycaemia severity, treatment choices and mortality despite similar patient demographics. Conclusions: The co-designed multicentre digital evaluation model for in-hospital hypoglycaemia was successfully implemented with high acceptability and feasibility. Key findings highlight gaps in management, including suboptimal treatment adherence and high recurrence rates. Addressing these issues through real-time monitoring, targeted interventions and improved guideline adherence could enhance patient outcomes. This standardised model could address differences in healthcare regionally and nationally for other conditions.
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1862035
Open AccessImplementing a multi-centre hypoglycaemia management surveillance model through a co-designed approach to develop actionable insights in the UK
Introduction: Severe hypoglycaemia is associated with increased mortality. While considered a never event, severe hypoglycaemias continue occurring in people admitted to hospital. Inconsistent data collection and surveillance limits our ability to assess trends, identify risk factors and implement targeted interventions. This study aimed to (1) co-design a multicentre audit model for inpatient hypoglycaemia (2), evaluate its acceptability and feasibility and (3) analyse hypoglycaemia management to inform quality improvement initiatives. Methods: A hypoglycaemia audit system was co-designed with diabetes specialists, resident doctors and medical students, guided by ERIC study recommendations and the CFIR framework. Piloted at one site, it then expanded to ten hospitals, where feasibility and acceptability were evaluated using stakeholder feedback and system performance. The model was delivered via Plan-Do-Study-Act cycles and train-the-trainer methods. Data on demographics, precipitants, treatments, and outcomes of clinically significant hypoglycaemias in people with diabetes were analysed to identify risk factors and adherence to guidelines. End-user and expert feedback informed system validation. Results: The system was refined via stakeholder input and Plan-Do-Study-Act cycles to ensure usability before expanding to ten hospitals, where it achieved high acceptability. Over 11 months, 1,451 severe hypoglycaemias in 945 patients were recorded. Common precipitants included illness and missed meals. Management varied significantly between hospitals, e.g., glucagon use ranged from 2.6% (Hospital C) to 38.7% (Hospital E). Two hospitals within the same NHS trust showed differences in hypoglycaemia severity, treatment choices and mortality despite similar patient demographics. Conclusions: The co-designed multicentre digital evaluation model for in-hospital hypoglycaemia was successfully implemented with high acceptability and feasibility. Key findings highlight gaps in management, including suboptimal treatment adherence and high recurrence rates. Addressing these issues through real-time monitoring, targeted interventions and improved guideline adherence could enhance patient outcomes. This standardised model could address differences in healthcare regionally and nationally for other conditions.
- Open Access
- 11 September 2026
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 26 (S2)
Integrating Digital Screening and Co-designed Pathways Improves Psychosocial Care, Patient Satisfaction, and Guideline Adherence in Polycystic Ovary Syndrome
Background: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine conditions in women, affecting over 10% of women worldwide. It is associated with significant reproductive, metabolic, and psychosocial burdens. In the UK, management remains fragmented, with limited coordination between primary and secondary care, time-constrained consultations, and inconsistent assessment of mental, reproductive, and physical health needs. Addressing these gaps requires an integrated, patient-centred approach that embeds psychosocial assessment and education within routine care. Approach: We developed PCOS SEva (Service Evaluation)—a digitally enabled, co-designed care model that standardises holistic PCOS consultations across NHS sites. The model integrates pre- and post-consultation digital surveys assessing anxiety/depression using the Hospital Anxiety and Depression Scale (HADS), body image using the Body Image Concern Inventory (BICI), sexual function using the Female Sexual Function Index (FSFI), quality of life using PCOS quality of Life survey (PCOSQoL), and hirsutism using modified Ferriman Galway Score (mFG), alongside post-consultation satisfaction and experience measures. The post-consultation survey included links to various educational resources. Clinical pathways for common PCOS presentations were co-designed with patients, endocrinologists, gynaecologists, general practitioners, and nurses. Multilingual, evidence-based patient resources—including educational videos on lifestyle management and common medications—were developed collaboratively with women with lived experience to address literacy and further translated to multiple languages to address language barriers. A mixed-methods Type 2 hybrid implementation–effectiveness study is being conducted from April 2025 to June 2026 at three NHS centres, using the Implementation Research Logic Model (IRLM) and Non-adoption, Abandonment, Scale-up, Spread, Sustainability complexity assessment toolkit (NASSS-CAT) frameworks. These guided evaluations of contextual complexity, adoption, and fidelity. Implementation strategies, informed by ERIC, included clinician training, audit and feedback, and integration of PCOS SEva pathways into local clinical guidelines. Semi-structured interviews with ~10 stakeholders at each phase (baseline, interim, and follow-up) will be thematically analysed using Braun and Clarke’s approach. Results: To date, 33 women have completed pre-consultation surveys and 25 post-consultation surveys. Median age was 30 years, and median BMI 34.3 kg/m². Delays to diagnosis were common, with a median time of 18 months from first healthcare contact. Over 60% of respondents reported receiving little or no information on fertility or long-term complications at diagnosis. High levels of psychological distress were observed (48% moderate–severe anxiety; 39% mild–moderate depression), and >70% reported significant body image concerns. Following the PCOS SEva consultation, 96% rated their experience as “good” or “very good,” 84% felt actively involved in decision-making, and 88% were likely or very likely to recommend the clinic to others. Interviews highlighted improved clinician awareness of psychosocial needs, enhanced patient engagement, and seamless integration of digital tools into workflows. Implications: PCOS SEva demonstrates the feasibility and acceptability of embedding holistic, digitally supported care within routine clinical practice. Early findings suggest an improved patient experience and increased provider engagement, with potential for scalability across diverse NHS settings. This co-designed model aligns with 2023 international PCOS care recommendations and offers a transferable framework for integrating psychosocial care into PCOS management.
- 11 September 2026
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 26 (S2)
Open AccessIntegrating Digital Screening and Co-designed Pathways Improves Psychosocial Care, Patient Satisfaction, and Guideline Adherence in Polycystic Ovary Syndrome
Background: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine conditions in women, affecting over 10% of women worldwide. It is associated with significant reproductive, metabolic, and psychosocial burdens. In the UK, management remains fragmented, with limited coordination between primary and secondary care, time-constrained consultations, and inconsistent assessment of mental, reproductive, and physical health needs. Addressing these gaps requires an integrated, patient-centred approach that embeds psychosocial assessment and education within routine care. Approach: We developed PCOS SEva (Service Evaluation)—a digitally enabled, co-designed care model that standardises holistic PCOS consultations across NHS sites. The model integrates pre- and post-consultation digital surveys assessing anxiety/depression using the Hospital Anxiety and Depression Scale (HADS), body image using the Body Image Concern Inventory (BICI), sexual function using the Female Sexual Function Index (FSFI), quality of life using PCOS quality of Life survey (PCOSQoL), and hirsutism using modified Ferriman Galway Score (mFG), alongside post-consultation satisfaction and experience measures. The post-consultation survey included links to various educational resources. Clinical pathways for common PCOS presentations were co-designed with patients, endocrinologists, gynaecologists, general practitioners, and nurses. Multilingual, evidence-based patient resources—including educational videos on lifestyle management and common medications—were developed collaboratively with women with lived experience to address literacy and further translated to multiple languages to address language barriers. A mixed-methods Type 2 hybrid implementation–effectiveness study is being conducted from April 2025 to June 2026 at three NHS centres, using the Implementation Research Logic Model (IRLM) and Non-adoption, Abandonment, Scale-up, Spread, Sustainability complexity assessment toolkit (NASSS-CAT) frameworks. These guided evaluations of contextual complexity, adoption, and fidelity. Implementation strategies, informed by ERIC, included clinician training, audit and feedback, and integration of PCOS SEva pathways into local clinical guidelines. Semi-structured interviews with ~10 stakeholders at each phase (baseline, interim, and follow-up) will be thematically analysed using Braun and Clarke’s approach. Results: To date, 33 women have completed pre-consultation surveys and 25 post-consultation surveys. Median age was 30 years, and median BMI 34.3 kg/m². Delays to diagnosis were common, with a median time of 18 months from first healthcare contact. Over 60% of respondents reported receiving little or no information on fertility or long-term complications at diagnosis. High levels of psychological distress were observed (48% moderate–severe anxiety; 39% mild–moderate depression), and >70% reported significant body image concerns. Following the PCOS SEva consultation, 96% rated their experience as “good” or “very good,” 84% felt actively involved in decision-making, and 88% were likely or very likely to recommend the clinic to others. Interviews highlighted improved clinician awareness of psychosocial needs, enhanced patient engagement, and seamless integration of digital tools into workflows. Implications: PCOS SEva demonstrates the feasibility and acceptability of embedding holistic, digitally supported care within routine clinical practice. Early findings suggest an improved patient experience and increased provider engagement, with potential for scalability across diverse NHS settings. This co-designed model aligns with 2023 international PCOS care recommendations and offers a transferable framework for integrating psychosocial care into PCOS management.
- Open Access
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1836949
Implementing a digital audit-and-feedback surveillance system for diabetic ketoacidosis: study protocol for the DEKODE programme
Introduction: Diabetic ketoacidosis is one of the leading causes of unplanned hospital admission among people with diabetes, yet adherence to treatment guidelines remains inconsistent, contributing to variation in care and suboptimal outcomes. Conventional audit approaches are limited by non-standardised data collection, restricting benchmarking and shared learning. The Digital Evaluation of Ketosis and Other Diabetic Emergencies (DEKODE) platform was developed as a cloud-based audit-and-feedback system to support near real-time performance monitoring and continuous quality improvement, but its implementation requires theory-informed evaluation. Methods: This multi-site, mixed-methods study involves six National Health Service hospitals, including early adopters and sites new to DEKODE. Guided by an implementation research logic model, the study links contextual determinants to tailored strategies. Quantitative outcomes, including episode duration, guideline adherence, complications, and clinical outcomes, will be analysed using interrupted time series methods. Qualitative stakeholder interviews will be analysed thematically, and findings integrated using triangulation. Results: The study will assess the impact of DEKODE on clinical and process outcomes and identify determinants influencing adoption, fidelity, and sustainability. Discussion: Findings will inform scalable implementation of digital audit-and-feedback systems to reduce variation in acute diabetes care and improve patient outcomes. Clinical Trial Registration: https://www.isrctn.com/ISRCTN17096714 , identifier ISRCTN17096714.
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1836949
Open AccessImplementing a digital audit-and-feedback surveillance system for diabetic ketoacidosis: study protocol for the DEKODE programme
Introduction: Diabetic ketoacidosis is one of the leading causes of unplanned hospital admission among people with diabetes, yet adherence to treatment guidelines remains inconsistent, contributing to variation in care and suboptimal outcomes. Conventional audit approaches are limited by non-standardised data collection, restricting benchmarking and shared learning. The Digital Evaluation of Ketosis and Other Diabetic Emergencies (DEKODE) platform was developed as a cloud-based audit-and-feedback system to support near real-time performance monitoring and continuous quality improvement, but its implementation requires theory-informed evaluation. Methods: This multi-site, mixed-methods study involves six National Health Service hospitals, including early adopters and sites new to DEKODE. Guided by an implementation research logic model, the study links contextual determinants to tailored strategies. Quantitative outcomes, including episode duration, guideline adherence, complications, and clinical outcomes, will be analysed using interrupted time series methods. Qualitative stakeholder interviews will be analysed thematically, and findings integrated using triangulation. Results: The study will assess the impact of DEKODE on clinical and process outcomes and identify determinants influencing adoption, fidelity, and sustainability. Discussion: Findings will inform scalable implementation of digital audit-and-feedback systems to reduce variation in acute diabetes care and improve patient outcomes. Clinical Trial Registration: https://www.isrctn.com/ISRCTN17096714 , identifier ISRCTN17096714.
- Open Access
- 18 August 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 195 (3) , 406-420
SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality
Background: Type 2 diabetes mellitus (T2DM) is often the first condition on the pathway to patients developing multiple long-term conditions (MLTCs). The impact of sodium-glucose cotransporter 2 inhibitors (SGLT-2i), a key T2DM treatment, on hospitalization and MLTC progression remains uncertain. Methods: In this comparative effectiveness study, we emulated a target trial using linked primary care, hospital, and mortality records in England (2012-2023). Adults aged ≥40 years with T2DM initiating SGLT-2i or dipeptidyl peptidase-4 inhibitors (DPP-4i) were included (n = 364 522). Outcomes included all-cause mortality, first hospitalization, number of hospitalizations, and incidence of 59 prespecified long-term conditions across 17 organ systems. Weighted Cox proportional hazards and negative binomial regression models were used to estimate adjusted hazard ratios (aHRs) or adjusted mean differences (aMDs), with 95% CIs and Benjamini–Yekutieli correction for multiple testing. Findings: Compared with DPP-4i, SGLT-2i use was associated with lower risks of all-cause mortality (aHR 0.73, 95% CI 0.71-0.75), first hospitalization (aHR 0.86, 95% CI 0.85-0.87), and number of hospitalizations (aMD –0.36, 95% CI –0.38 to –0.34; all P < .001). SGLT-2i initiators had reduced risks for 28 conditions, including dementia, cancer, metabolic dysfunction–associated steatotic liver disease, diabetic foot ulcer, epilepsy, and rheumatoid arthritis. Increased risks were observed for four conditions, including candidiasis and diabetic ketoacidosis. Interpretation: SGLT-2i use in T2DM was associated with significant reductions in mortality, hospitalization, and MLTC burden. The broad protective effects across multiple organ systems highlight the potential of SGLT-2i to provide a holistic therapeutic strategy in the management of diabetes and its multisystem complications.
- 18 August 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 195 (3) , 406-420
Open AccessSGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality
Background: Type 2 diabetes mellitus (T2DM) is often the first condition on the pathway to patients developing multiple long-term conditions (MLTCs). The impact of sodium-glucose cotransporter 2 inhibitors (SGLT-2i), a key T2DM treatment, on hospitalization and MLTC progression remains uncertain. Methods: In this comparative effectiveness study, we emulated a target trial using linked primary care, hospital, and mortality records in England (2012-2023). Adults aged ≥40 years with T2DM initiating SGLT-2i or dipeptidyl peptidase-4 inhibitors (DPP-4i) were included (n = 364 522). Outcomes included all-cause mortality, first hospitalization, number of hospitalizations, and incidence of 59 prespecified long-term conditions across 17 organ systems. Weighted Cox proportional hazards and negative binomial regression models were used to estimate adjusted hazard ratios (aHRs) or adjusted mean differences (aMDs), with 95% CIs and Benjamini–Yekutieli correction for multiple testing. Findings: Compared with DPP-4i, SGLT-2i use was associated with lower risks of all-cause mortality (aHR 0.73, 95% CI 0.71-0.75), first hospitalization (aHR 0.86, 95% CI 0.85-0.87), and number of hospitalizations (aMD –0.36, 95% CI –0.38 to –0.34; all P < .001). SGLT-2i initiators had reduced risks for 28 conditions, including dementia, cancer, metabolic dysfunction–associated steatotic liver disease, diabetic foot ulcer, epilepsy, and rheumatoid arthritis. Increased risks were observed for four conditions, including candidiasis and diabetic ketoacidosis. Interpretation: SGLT-2i use in T2DM was associated with significant reductions in mortality, hospitalization, and MLTC burden. The broad protective effects across multiple organ systems highlight the potential of SGLT-2i to provide a holistic therapeutic strategy in the management of diabetes and its multisystem complications.
- Open Access
- 3 August 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 195 (2) , 365-371
Body image concern in women with polyendocrine metabolic ovarian syndrome (PMOS): a comparative analysis of 2 assessment tools
Objective: Body image dissatisfaction is common in women with polyendocrine metabolic ovarian syndrome (PMOS), yet optimal assessment tools remain unclear. This study compared the Body Image Concern Inventory (BICI) and the Multidimensional Body-Self Relations Questionnaire—Appearance Scales (MBSRQ-AS) in women with PMOS, evaluating agreement, reliability, and associations with clinical and demographic characteristics. Design: This was a multicenter cross-sectional observational study. Methods: A total of 163 women were recruited from specialist clinics and community settings in the United Kingdom between June 2023 and October 2024. Body image was assessed using the BICI and MBSRQ-AS, alongside clinical and sociodemographic variables. Internal consistency, correlations, and multivariable regression analyses were performed to evaluate associations and predictors of clinically significant body image concern. Results: The BICI was significantly associated with body mass index and hirsutism scores. Higher body mass index was associated with worse scores across the MBSRQ-AS subscales. BICI scores correlated negatively with Appearance Evaluation and Body Areas Satisfaction and positively with Overweight Preoccupation and Appearance Orientation (all P < .001). Hierarchical regression analysis showed that MBSRQ-AS scores explained additional variance in the BICI scores beyond clinical features, indicating distinct contributions to body image assessment. Conclusion: Both tools capture distinct dimensions of body image in women with PMOS. The selection of assessment tools should be context-driven to optimally address body image concerns in this population.
- 3 August 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 195 (2) , 365-371
Open AccessBody image concern in women with polyendocrine metabolic ovarian syndrome (PMOS): a comparative analysis of 2 assessment tools
Objective: Body image dissatisfaction is common in women with polyendocrine metabolic ovarian syndrome (PMOS), yet optimal assessment tools remain unclear. This study compared the Body Image Concern Inventory (BICI) and the Multidimensional Body-Self Relations Questionnaire—Appearance Scales (MBSRQ-AS) in women with PMOS, evaluating agreement, reliability, and associations with clinical and demographic characteristics. Design: This was a multicenter cross-sectional observational study. Methods: A total of 163 women were recruited from specialist clinics and community settings in the United Kingdom between June 2023 and October 2024. Body image was assessed using the BICI and MBSRQ-AS, alongside clinical and sociodemographic variables. Internal consistency, correlations, and multivariable regression analyses were performed to evaluate associations and predictors of clinically significant body image concern. Results: The BICI was significantly associated with body mass index and hirsutism scores. Higher body mass index was associated with worse scores across the MBSRQ-AS subscales. BICI scores correlated negatively with Appearance Evaluation and Body Areas Satisfaction and positively with Overweight Preoccupation and Appearance Orientation (all P < .001). Hierarchical regression analysis showed that MBSRQ-AS scores explained additional variance in the BICI scores beyond clinical features, indicating distinct contributions to body image assessment. Conclusion: Both tools capture distinct dimensions of body image in women with PMOS. The selection of assessment tools should be context-driven to optimally address body image concerns in this population.
- Open Access
- 14 July 2026
- Published by Springer Nature
Improving care for people admitted with diabetes-related emergencies
- 14 July 2026
- Published by Springer Nature
Open AccessImproving care for people admitted with diabetes-related emergencies